Home
  • Rankings
  • Fortune 500 India
    Most Powerful Women
    The Next 500
    Forty Under Forty
    Best B-Schools
    MNC 500
  • Profiles
  • Companies
    People
  • Business
  • Markets
  • Cryptocurrency
    IPO
    Stock Market
  • Economy
  • Personal Finance
  • Tax
    Mutual Funds
    Banking
  • Opinion
    Technology
    Auto
    Lifestyle
    Long Reads
    First Edit
    Ideas
    Buy on Amazon
    Magazine Annual Subscription
  • Archives
  • Enterprise
    Investing
    Macro
    Infographics
  • Home
    • News
      • Business
      • Markets
      • Economy
      • Personal Finance
      • Opinion
      • Technology
      • Auto
      • Lifestyle
    • Media
      • Videos
      • Short Videos
      • Visual Stories
    • Magazine
      • June 2025
      • May 2025
      • April 2025
      • March 2025
      • February 2025
      • January 2025
    • Rankings
      • Fortune 500 India
      • Most Powerful Women
      • The Next 500
      • Forty Under Forty
      • Best B-Schools
      • MNC 500
    • Profiles
      • Companies
      • People

Aurobindo Pharma

(7 search results)

Aurobindo Pharma announces share buyback worth ₹750 cr; stock drops 2%

Aurobindo Pharma announces share buyback worth ₹750 cr; stock drops 2%

Jul 18, 2024 11:28am IST
Aurobindo Pharma shares rise 2% on USFDA nod for nasal spray

Aurobindo Pharma shares rise 2% on USFDA nod for nasal spray

Mar 20, 2024 10:18am IST
Aurobindo Pharma arm to sell asset in $52 mn deal; stock dips

Aurobindo Pharma arm to sell asset in $52 mn deal; stock dips

Feb 5, 2024 11:38am IST
Aurobindo Pharma arm gets US FDA nod for posaconazole injection; share up 1.6%

Aurobindo Pharma arm gets US FDA nod for posaconazole injection; share up 1.6%

Dec 27, 2023 3:30pm IST
Aurobindo Pharma shares rise 2% on USFDA approval for asthma drug

Aurobindo Pharma shares rise 2% on USFDA approval for asthma drug

Nov 30, 2023 1:53pm IST
Aurobindo Pharma swings to 52-week high; here's why

Aurobindo Pharma swings to 52-week high; here's why

Nov 20, 2023 1:06pm IST
Aurobindo Pharma hits 52-week high despite 12% decline in PAT in Q4; here's why

Aurobindo Pharma hits 52-week high despite 12% decline in PAT in Q4; here's why

May 30, 2023 2:19pm IST
HomeTopicAurobindo Pharma
Follow us
Published by the RP-Sanjiv Goenka Group, Fortune India - the Indian edition of Fortune magazine - sets the benchmark for editorial excellence and thought leadership in Indian business journalism.
Rankings
  • Fortune 500 India
  • Most Powerful Women
  • The Next 500
  • Forty Under Forty
  • Best B-Schools
  • MNC 500
Profiles
  • Companies
  • People
Most Read Sections
  • Business
  • Markets
  • Economy
  • Personal Finance
  • Opinion
Media
  • Videos
  • Short Videos
  • Visual Stories
Magazines
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • Privacy & Cookie Policy
  • Terms of Use
  • Vision & Core Values
  • Contact Us
© 2025 Fortune India. All Rights Reserved.